Skip to main content
The Globe and Mail
Support Quality Journalism.
The Globe and Mail
First Access to Latest
Investment News
Collection of curated
e-books and guides
Inform your decisions via
Globe Investor Tools
per week
for first 24 weeks

Enjoy unlimited digital access
Enjoy Unlimited Digital Access
Get full access to
Just $1.99 per week for the first 24 weeks
Just $1.99 per week for the first 24 weeks
var select={root:".js-sub-pencil",control:".js-sub-pencil-control",open:"o-sub-pencil--open",closed:"o-sub-pencil--closed"},dom={},allowExpand=!0;function pencilInit(o){var e=arguments.length>1&&void 0!==arguments[1]&&arguments[1];select.root=o,dom.root=document.querySelector(select.root),dom.root&&(dom.control=document.querySelector(select.control),dom.control.addEventListener("click",onToggleClicked),setPanelState(e),window.addEventListener("scroll",onWindowScroll),dom.root.removeAttribute("hidden"))}function isPanelOpen(){return dom.root.classList.contains(}function setPanelState(o){dom.root.classList[o?"add":"remove"](,dom.root.classList[o?"remove":"add"](select.closed),dom.control.setAttribute("aria-expanded",o)}function onToggleClicked(){var l=!isPanelOpen();setPanelState(l)}function onWindowScroll(){window.requestAnimationFrame(function() {var l=isPanelOpen(),n=0===(document.body.scrollTop||document.documentElement.scrollTop);n||l||!allowExpand?n&&l&&(allowExpand=!0,setPanelState(!1)):(allowExpand=!1,setPanelState(!0))});}pencilInit(".js-sub-pencil",!1); // via darwin-bg var slideIndex = 0; carousel(); function carousel() { var i; var x = document.getElementsByClassName("subs_valueprop"); for (i = 0; i < x.length; i++) { x[i].style.display = "none"; } slideIndex++; if (slideIndex> x.length) { slideIndex = 1; } x[slideIndex - 1].style.display = "block"; setTimeout(carousel, 2500); } //

In 1983, 44 lung transplants had been performed around the world and 44 had failed. All of the patients died within days or weeks.

But for Tom Hall, a Toronto man suffering from idiopathic pulmonary fibrosis (scarring of the lungs), a transplant was the only hope, a "shot in the dark," as his doctor said, even though the three other lung transplants attempted in Toronto had been unsuccessful.

Presented with the grim odds, Hall told the doctor: "It would be a privilege to be patient 45."

Story continues below advertisement

He not only survived, but thrived, going from his death bed at age 58 to living another 61/2 years and, in the process, helping make Toronto General Hospital a world-renowned transplant centre.

This week in Toronto, the 30th anniversary of Hall's groundbreaking surgery is being honoured. Canadians may not be very good at celebrating success, but lung transplantation is a uniquely Canadian success story. So on Wednesday, health professionals and patients will gather at the Four Seasons Hotel in Toronto for a "birthday" party, and they will watch a tug-at-the-heartstrings video entitled simply "45."

The occasion is important for a couple of reasons. It's a reminder just how far medicine has come in a relatively short time, with lung transplants going from the realm of science fiction to comparatively routine procedures (as much as any transplant surgery can be considered routine).

The idea of doing lung transplants dates back to the 1940s and, for a long time, experiments conducted on dogs often ended in frustration. The invention of the heart-lung bypass machine in the late-1950s, however, enhanced the possibility of success.

The first human lung transplant was performed in Jackson, Miss., in 1963 – on convicted murderer John Richard Russell. He agreed to serve as a human guinea pig, and lived 18 days after the surgery. (Suffice to say that ethics rules were a little more lax at the time.)

Over the next two decades, there were dozens of desperate surgeries, all ending in failure. The problem was two-fold: Lungs are very fragile and can be badly damaged in the transplant process; and the body is programmed to reject foreign intrusions, even potentially lifesaving organs.

In the early 1980s, cyclosporine – an anti-rejection drug – was approved for use, and it revolutionized transplantation. Researchers and physicians also found new ways to preserve lungs in the crucial hours between their removal from a brain-dead donor and transplantation into a recipient, and surgeons honed their skills.

Story continues below advertisement

The innovation that kept Hall alive longer than others was a surgeon's hunch – he took the omentum (fatty tissue in the abdomen known for its healing properties) and wrapped it around the new lung.

After Hall's operation, surgeons stayed in his room around-the-clock for weeks to monitor his condition. They were understandably concern: In 1983, medical experts had almost given up on lung transplantion because of repeated failures. But Hall's case, a successful single lung transplant, opened the door to a series of dramatic advances.

Since then, more than 100,000 lung transplants have been performed worldwide. In 1986, the first successful double-lung transplant was done. Also in 1986, the first lung transplant was done on a child. Then, in 1988, the first double-lung transplant on a patient with cystic fibrosis was performed.

All of these milestones were achieved at Toronto General Hospital (now part of the University Health Network).

"It's quite a remarkable record, and we're really proud of it," Dr. Shafique Keshavjee, surgeon-in-chief at University Health Network and director the Toronto Lung Transplant Program, said in an interview.

Since the dramatic breakthroughs of the early years, there have been slow but steady improvements, especially in harvesting and preserving donor lungs, many of them the work of Keshavjee and his team.

Story continues below advertisement

As a result, the number of transplants has soared, and so has the survival rate.

Last year in Canada, there were 232 lung transplants; per capita that is the highest rate in the world. But at the beginning of this year, there were 318 people on waiting lists because of the severe shortage of donors. Transplants are done principally for patients with cystic fibrosis, chronic obstructive pulmonary disease, emphysema and pulmonary hypertension.

(Since 2000, it has been possible to do lung transplants from living donors, but the technique requires two people to each donate one lobe of a lung, so it is only used as a last resort.)

The one-year survival rate is 85 per cent, and over 10 years the rate is almost 30 per cent. The Toronto program has 22 patients who have survived 20 years or more after their lung transplants.

The next innovation will likely be a shift to regenerative medicine, using gene therapy and stem-cell therapy to repair lungs in sick patients. This will – theoretically at least – reduce the need for donated organs and virtually eliminate the problem of rejection. A gene-therapy trial begins in Toronto next year.

"Ultimately the goal is to never have to do a lung transplant," Keshavjee said.

Story continues below advertisement

Until then, it's worth remembering patient 45, and celebrating how far we've come.

Your Globe

Build your personal news feed

  1. Follow topics and authors relevant to your reading interests.
  2. Check your Following feed daily, and never miss an article. Access your Following feed from your account menu at the top right corner of every page.

Follow the author of this article:

View more suggestions in Following Read more about following topics and authors
Report an error Editorial code of conduct
Due to technical reasons, we have temporarily removed commenting from our articles. We hope to have this fixed soon. Thank you for your patience. If you are looking to give feedback on our new site, please send it along to If you want to write a letter to the editor, please forward to

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff.

We aim to create a safe and valuable space for discussion and debate. That means:

  • Treat others as you wish to be treated
  • Criticize ideas, not people
  • Stay on topic
  • Avoid the use of toxic and offensive language
  • Flag bad behaviour

If you do not see your comment posted immediately, it is being reviewed by the moderation team and may appear shortly, generally within an hour.

We aim to have all comments reviewed in a timely manner.

Comments that violate our community guidelines will not be posted.

Read our community guidelines here

Discussion loading ...

To view this site properly, enable cookies in your browser. Read our privacy policy to learn more.
How to enable cookies